People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...
Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...
Type 1 diabetes (T1D) is an autoimmune condition where the body cannot produce insulin properly, and this can affect the life ...
A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...
The technology has been described as a step ... guidelines to minimise the risk of long-term complications from diabetes. Hybrid closed loops systems are only recommended if the companies and ...
MORE than half of adults living with type 1 diabetes believe the condition stops them from being more spontaneous. A poll of ...
2d
Given these compelling results, Creative Medical Technology plans to advance the development of AlloStem (CELZ-201) for the treatment of late-stage Type 2 Diabetes and explore other potential ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback